Therorna
Clinical trials sponsored by Therorna, explained in plain language.
-
One-Shot gene therapy tested to halt devastating autoimmune attacks
Disease control Recruiting nowThis early-stage study is testing a new, one-time treatment called TI-0032-III for people with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard drugs. The treatment uses an injection to genetically reprogram the patient's own immune cells …
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New shot tested for Tough-to-Treat HPV cancers
Disease control Recruiting nowThis is a very early study to check the safety and find the right dose of a new injection called TI-0093. It is for people with advanced head, neck, or cervical cancers linked to HPV-16 that have come back or spread after standard treatments. The main goals are to see what side e…
Phase: PHASE1 • Sponsor: Therorna • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC